Cancer antigen 125 levels are elevated (⩾35 U ml−1) in 82% of newly diagnosed ovarian carcinoma patients and in 74% of patients, the CA125 level is above 65 U ml−1 (Bast et al, 1983; Tuxen et al, 1995). Here, MUC16 is linked to ovarian carcinoma.